Balanced news tone
News Sentiment
HYFT sentiment intelligence
ImmunoPrecise Antibodies Ltd. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
78/100 classification confidence.
directly relevant articles
high-authority source matches
+2.1% over one week, -4.6% over four weeks, trend inactive, and near fair-value range.
H.C. Wainwright reiterates Buy on MindWalk stock, $5 target
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
H.C. Wainwright reiterates Buy on MindWalk stock, $5 target
H.C. Wainwright has reiterated its Buy rating and $5.00 price target for MindWalk Holdings (NASDAQ:HYFT), citing the company's strong revenue growth, expanding gross margins, and potential from its proprietary pipeline and LensAI revenue. MindWalk recently announced inclusion in
- Tone
- Positive 90/100
- Event
- Analyst action
- Published
- 20 Jul 2026 12:09
- Source
- Investing.com
MindWalk (NASDAQ: HYFT) CEO Dr. Jennifer Bath to Join Absci (NASDAQ: ABSI) and a Leading AI Compute Provider on Jones AI Day Panel on the Future of AI Drug Discovery
MindWalk Holdings Corp. (NASDAQ: HYFT) announced that its CEO, Dr. Jennifer Bath, will participate in a virtual panel hosted by Jones AI Day on June 15, 2026. The panel, titled "Partnering to Power the New Era of Drug Discovery," will discuss how advanced computing, biological kn
- Tone
- Positive 71/100
- Event
- Market update
- Published
- 18 Jul 2026 10:11
- Source
- The National Law Review
Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 16 Jul 2026 18:49
- Source
- Market source
MindWalk Holdings (Nasdaq: HYFT) plans $250M shelf for stock, debt and warrants
MindWalk Holdings Corp. (Nasdaq: HYFT) has filed a replacement shelf registration statement (Form F-3) to offer up to $250 million in various securities, including common and preferred shares, debt, warrants, units, and subscription receipts, over the next 36 months. This filing
- Tone
- Neutral 50/100
- Event
- Balance sheet
- Published
- 13 Jul 2026 19:41
- Source
- Stock Titan
MindWalk Holdings to report Q4 and FY26 results on July 22
MindWalk Holdings Corp. (NASDAQ: HYFT) announced it will release its financial results for the fourth quarter and full fiscal year 2026 on July 22, 2026. The Bio-Native AI company will hold a conference call at 5:00 p.m. ET on the same day to discuss the results and recent busine
- Tone
- Positive 72/100
- Event
- Earnings
- Published
- 13 Jul 2026 16:39
- Source
- scanx.trade
MindWalk Holdings Corp. (NASDAQ: HYFT) schedules Q4 and full-year 2026 earnings call
MindWalk Holdings Corp. (NASDAQ: HYFT), a Bio-Native AI company, will announce its financial results for the fourth quarter and full fiscal year 2026 on July 22, 2026. The company will host a conference call and webcast at 5:00 p.m. Eastern Time on the same day, following the rel
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 13 Jul 2026 16:39
- Source
- Stock Titan
Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 13 Jul 2026 07:00
- Source
- Market source
Russell 3000E addition expands MindWalk (NASDAQ: HYFT) index access
MindWalk Holdings Corp. (NASDAQ: HYFT), a Bio-Native AI company, has been added to the Russell 3000E Index, effective June 26, 2026, as part of FTSE Russell’s semi-annual reconstitution. This inclusion enhances MindWalk's visibility to institutional investors and index-tracking f
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 06 Jul 2026 14:11
- Source
- Stock Titan
MindWalk added to Russell 3000E Index effective June 26
MindWalk Holdings Corp. (NASDAQ:HYFT) has been added to the Russell 3000E Index, effective June 26, 2026, a move expected to increase the company's visibility among institutional investors and index-tracking funds. The inclusion, part of FTSE Russell's semi-annual reconstitution,
- Tone
- Positive 70/100
- Event
- Market update
- Published
- 06 Jul 2026 13:11
- Source
- Investing.com
MindWalk Holdings Corp. (NASDAQ: HYFT) Added to the Russell 3000E Index, Expanding Institutional Investment Opportunity
MindWalk Holdings Corp. (NASDAQ: HYFT), a Bio-Native AI company, was added to the Russell 3000E Index, effective June 26, 2026, as part of the FTSE Russell June 2026 semi-annual reconstitution. This inclusion enhances MindWalk's visibility among institutional investors and index-
- Tone
- Positive 73/100
- Event
- Market update
- Published
- 06 Jul 2026 12:30
- Source
- Market source
As AI Models Become Commodities, One Bio-Native AI Company Just Moved to Patent the Thing That Actually Compounds: the Data
MindWalk Holdings Corp. (NASDAQ: HYFT) has filed a foundational European patent application for its multi-dimensional data architecture, HYFT® Technology. This move aims to protect the enriched biological data layer that its AI platforms, ReefIQ™ and LensAI™, operate on. The comp
- Tone
- Positive 76/100
- Event
- Market update
- Published
- 03 Jul 2026 03:09
- Source
- Sahm
H.C. Wainwright reiterates Buy on MindWalk stock, $5 target By Investing.com
H.C. Wainwright has reiterated a Buy rating and a $5.00 price target for MindWalk Holdings (NASDAQ:HYFT) stock. This affirmation follows MindWalk's recent filing of a European patent application for high-dimensional data structures for biological sub-sequences, and separate news
- Tone
- Positive 74/100
- Event
- Analyst action
- Published
- 02 Jul 2026 11:40
- Source
- Investing.com Canada
MindWalk (NASDAQ: HYFT) Files Patent for High-Dimensional Biological Data Architecture Powering AI Drug Discovery
MindWalk (NASDAQ: HYFT) has filed a European patent application for a high-dimensional biological data architecture designed to power AI drug discovery. This patent protects an enriched biological representation layer, building upon their foundational HYFT patent, to organize bio
- Tone
- Positive 74/100
- Event
- Market update
- Published
- 01 Jul 2026 15:11
- Source
- Market source
MindWalk (NASDAQ: HYFT) seeks EU patent on AI-driven biological data layer
MindWalk Holdings Corp. (NASDAQ: HYFT) has filed a European patent application for an AI-driven high-dimensional biological data architecture, EP26187897.9, which underpins its HYFT® Technology, ReefIQ™, and LensAI™ workflows for drug discovery. The patent aims to protect a novel
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 01 Jul 2026 14:10
- Source
- Stock Titan
MindWalk Holdings Corp. (NASDAQ: HYFT) Launches ReefIQ™, a Biological Context Layer for AI Drug Discovery
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jun 2026 13:16
- Source
- Business Wire
MindWalk's Preclinical Dengue Data Support a HYFT® Computational Prediction: Immunogens Designed on the Predicted Target Elicited Cross-Reactive Antibodies Against Antigens of All Four Dengue Serotypes, Reproduced Across Two Independent Campaigns
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 02 Jun 2026 11:20
- Source
- Business Wire
There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 15 May 2026 07:00
- Source
- simplywall.st
Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 May 2026 07:00
- Source
- Market source
Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- simplywall.st
Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- Market source
Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Apr 2026 07:00
- Source
- Market source
Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 Apr 2026 07:00
- Source
- Market source
A Look Back at Biotechnology Stocks’ Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 29 Mar 2026 07:00
- Source
- TradingView
MindWalk Holdings Corp.'s (NASDAQ:HYFT) P/S Is Still On The Mark Following 38% Share Price Bounce
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jan 2026 08:00
- Source
- simplywall.st
HYFT Stock Price and Chart — NASDAQ:HYFT
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Dec 2025 08:00
- Source
- TradingView
Immunoprecise (IPA) Stock Price, News & Analysis
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 Apr 2025 00:34
- Source
- Stock Titan
ImmunoPrecise Advances Anti-Aging Research with Mayo Clinic Study, Poised to Tap into $81 Billion Market with AI Technology
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 Oct 2024 07:00
- Source
- Stock Titan
Paul Andreola: ImmunoPrecise & Stock Picking In The Small Cap Arena – The Daily Dive
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Aug 2021 17:42
- Source
- the deep dive
ImmunoPrecise Antibodies (IPA) Stock Price, News & Analysis $IPA
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Jan 2021 23:56
- Source
- MarketBeat